A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease

P. Holmans, V. Moskvina, L. Jones, M. Sharma, A. Vedernikov, F. Buchel, M. Sadd, J.M. Bras, F. Bettella, N. Nicolaou, J. Simon Sanchez, F. Mittag, J.R. Gibbs, C. Schulte, A. Durr, R. Guerreiro, D. Hernandez, A. Brice, H. Stefánsson, K. MajamaaT. Gasser, P. Heutink, N.W. Wood, M. Martinez, A.B. Singleton, M.A. Nalls, J. Hardy, H.R. Morris, N.M. Williams, Z. Bochdanovits

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease affecting 1-2% in people >60 and 3-4% in people >80. Genome-wide association (GWA) studies have now implicated significant evidence for association in at least 18 genomic regions. We have studied a large PD-meta analysis and identified a significant excess of SNPs (P < 1 × 10
Original languageEnglish
Pages (from-to)1039-1049
JournalHuman Molecular Genetics
Volume22
Issue number5
DOIs
Publication statusPublished - 2013

Bibliographical note

International Parkinson's Disease Genomics Consortium

Fingerprint

Dive into the research topics of 'A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease'. Together they form a unique fingerprint.

Cite this